نتایج جستجو برای: pharmaceutical market

تعداد نتایج: 240989  

Journal: :archives of razi institute 2016
s.a.a. torabi a. alipour h. ghasemi

the purpose of this paper is to make explicit how companies in pharmaceutical sector can ensure their position in different markets by relying on a sustainable competitive advantages resulted from using a good defined marketing model. various factors are highlighted including high research and development roles and costs, hard government regulation in frame of gmp standard, market analysis tool...

Journal: : 2022

At present, the importance of pharmaceutical sector economy has increased significantly in public perception. This review provides up-to-date information at beginning 2022 on main trends global market. Among current are: key role pharmaceuticals fight against SARS-Covid-19 pandemic, problems a latent pandemic drug-resistant infections, high cost new drugs and an increase market share cheap bios...

Journal: :Journal of Intercultural Ethnopharmacology 2012

B Imani F Kalani

Introduction: Infants born with congenital anomalies demand individualized nutritional evaluations and recommendations. The anatomical changes of neonatal surgical diseases create specific physiological constraints.Patients with different congenital anomalies have different nutritional support needs. It is essential to know the exact physiology of these anomalies in order to be able to manage a...

Journal: :international journal of pediatrics 0
b imani department of pediatric, picu dr.sheikh hospital, mashhad university of medical science (mums), mashhad, iran. f kalani department of pediatric, mashhad university of medical science(mums), mashhad, iran.

introduction: infants born with congenital anomalies demand individualized nutritional evaluations and recommendations. the anatomical changes of neonatal surgical diseases create specific physiological constraints.patients with different congenital anomalies have different nutritional support needs. it is essential to know the exact physiology of these anomalies in order to be able to manage a...

ژورنال: اقتصاد مالی 2020
سعید خدا بخش زاده سیدعبدالمجید جلایی اسفندآبادی محسن زاینده رودی,

وجود حبابهای قیمتی کالاها و داروهای پزشکی در بی‌ثباتی بازار دارویی نقشی اساسی ایفا می کند. از آنجا که بازار مواد دارویی در هر کشوری با سطح توسعه‌یافتگی آن کشور ارتباط مستقیم دارد، بررسی حبابی بودن بازار مواد دارویی، تاریخ‌گذاری و تعیین نوع حباب‌های موجود، یگانه یا چندگانه بودن آنها در بازار اهمیت ویژه ای دارد.در این مقالهاز الگوهای نوین کشف و تاریخ‌گذاری حباب چون GSADF و RADF، استفاده شده است. ...

Journal: :international journal of hospital research 2015
abbas saleh ardestani hadi varzeshkar

there are two major methods in predincing the pattern of share value in the stock market: fundamental analysis and technical analysis. i this study we developed a novel model for fundamental analysis of share price and validated it by predicting the behavior of phrama share price in tehran stock market. the efficiency of the fundamental method was compared with that of indicator-based technical...

2016
Omotayo Fatokun Mohamed IM Ibrahim Mohamed A Hassali

Malaysia is reliant on the availability of generic medicines to contain the rising national pharmaceutical expenditure. This paper assesses the factors determining the market entry of a new generic medicine following patent expiration on the innovator product in Malaysia. Data were gathered by using mail survey approach. The prevalidated Likert-scale questionnaire was mailed to all licensed mem...

2017
Abdol Majid Cheraghali

Population of Iran as a Middle Eastern country with its population growth rate of about 1.3% has passed 80 million in 2016. Iran has a young population and it was reported that in 2013 sixty percent of its population was under the age of 30. However, due to a substantial decrease in population growth rate and increase in life expectancy, Iran will face an aging population in coming decades. Wit...

Journal: :Journal of health economics 2008
Wesley Yin

I study the impact of the Orphan Drug Act (ODA), which established tax incentives for rare disease drug development. I examine the flow of new clinical drug trials for a large set of rare diseases. Among more prevalent rare diseases, the ODA led to a significant and sustained increase in new trials. The impact for less prevalent rare diseases was limited to an increase in the stock of drugs. Ta...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید